Phase 1 proof-of-concept study will evaluate the safety, tolerability, and pharmacokinetics of GlyphAgo and is designed to demonstrate therapeutic levels of agomelatine at lower d ...

In recent years, we’ve seen tremendous growth in diversity, equity, and inclusion initiatives. Many people have eagerly embraced these efforts, but some have criticized and resisted them, including ...